AUNA (AUNA) Stock Price & Analysis

AUNA (AUNA) fell 2.04% to USD 5.28 as of September 8, 2026 at 06:54 UTC, according to Nexqual real-time market data.

AUNA last closed at USD 5.39; the session ranged USD 5.25–5.35 on volume of 85,337 shares. Market capitalization is $391.02M, with a 52-week range of USD 4.09–6.85 (NYQ). Source: Nexqual, September 8, 2026 at 06:54 UTC.

Key Statistics (as of September 8, 2026 at 06:54 UTC)

PriceUSD 5.28
Change▼ 2.04% (down)
Previous CloseUSD 5.39
OpenUSD 5.36
Day RangeUSD 5.25 – 5.35
52-Week RangeUSD 4.09 – 6.85
Volume85,337 shares
Market Cap$391.02M
ExchangeNYQ

Technical Analysis (AUNA)

Nexqual's technical model rates AUNA "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 06:54 UTC.

Overall SignalSTRONG BUY
RSI (14)52.75 (neutral)
vs SMA50Above (USD 5.19)
MACD0.02 (positive)

Analyst Ratings (AUNA)

Wall Street analysts rate AUNA "None" based on 7 analysts, with a mean price target of USD 6.99 (range USD 5–9), per Nexqual as of September 8, 2026 at 06:54 UTC.

Consensus RatingNone
Analyst Count7
Mean TargetUSD 6.99
High TargetUSD 9
Low TargetUSD 5
Buy / Hold / Sell5 / 2 / 0

Earnings (AUNA)

Next Earnings Date2026-11-19
EPS EstimateUSD 0.26
Revenue Estimate$1.20B

Recent Earnings History

QuarterActual vs Estimate
2026-06-30USD 0.15 vs est 0.27 ▼ miss
2026-03-31USD 0.05 vs est 0.18 ▼ miss
2025-12-31USD 0.52 vs est 0.2 ▲ beat
2025-09-30USD 0.21 vs est 0.18 ▲ beat

Source: Nexqual, September 8, 2026 at 06:54 UTC.

Financials & Fundamentals (AUNA)

Total Revenue$4.67B
Revenue Growth (YoY)+13.20%
Gross Margin+36.89%
Operating Margin+13.09%
Profit Margin+0.35%
ROE+1.62%
Debt / Equity184.96
Current Ratio1.08
Total Cash$481.32M
Total Debt$3.80B
Free Cash Flow$314.98M

Source: Nexqual, September 8, 2026 at 06:54 UTC.

Financial Health Score (AUNA)

Nexqual rates AUNA's overall financial health "Mixed" across five dimensions, as of September 8, 2026 at 06:54 UTC.

GrowthWeak — Revenue -0% YoY (annual), declining
ProfitabilitySolid — Gross margin 37%, operating 13%
Balance SheetWeak — $481M cash vs $3.80B debt
Cash FlowSolid — FCF $315M, 7% margin
EfficiencyWeak — ROE 2%, ROA 5.2%

Ownership (AUNA)

Insider Ownership+8.89%
Institutional Ownership+74.06%
Shares Outstanding30.14M
Float27.44M
Short % of Float+2.76%

Source: Nexqual, September 8, 2026 at 06:54 UTC.

Leadership (AUNA)

AUNA is led by Jesús Antonio Zamora Leon (age 63), President, CEO & Executive Chairman of the Board, per Nexqual as of September 8, 2026 at 06:54 UTC.

President, CEO & Executive Chairman of the BoardJesús Antonio Zamora Leon (age 63)
CFO & Executive VPGisele Remy Ferrero (age 45)
Executive Vice President OperationsRayet Harb (age 52)
Chief Technology OfficerAbraham Galan

Major Backers & Investors (AUNA)

Notable institutional backers of AUNA include Morgan Stanley, Jane Street Group, LLC, Renaissance Technologies, according to Nexqual as of September 8, 2026 at 06:54 UTC.

Active Investors

InvestorStake
Morgan Stanley1.91%
Jane Street Group, LLC1.91%
Renaissance Technologies1.88%
Global Opportunities Portfolio1.86%
Marshall Wace LLP1.61%
SEI INSTITUTIONAL INVESTMENTS TRUST-SIIT Emerging Markets Equity Fund1.47%
Two Sigma Investments, LP1.05%
Verde Servicos Internacionais S.a.1.02%

Index Funds (Passive)

FundStake
BlackRock7.21%

Source: Nexqual, September 8, 2026 at 06:54 UTC.

Peers & Related Stocks

SymbolNamePriceChange
CTNMContineum Therapeutics, Inc.USD 16.7▼ 3.13%
ARDTArdent Health, Inc.USD 10.91▲ 0%
INTJIntelligent Group LimitedUSD 3.02▲ 0.67%
HGHamilton Insurance Group, Ltd.USD 35.6▲ 0.28%
PNTGThe Pennant Group, Inc.USD 38▲ 0.37%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:54 UTC. This page is informational and not investment advice.